跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Quadrotopic - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Quadrotopic
Approved
STANDARD
Quadrotopic
Ashford Pharmaceutical Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8ab75addc733da93
Company
Ashford Pharmaceutical Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
8ab75addc733da93
Drug Approval Philippines Name
Quadrotopic
Product Name
Quadrotopic
Registration Number
DR-XY18727
Brand Name
Quadrotopic
Generic Name
Tolnaftate/Clioquinol/Gentamicin (as sulfate)/ Betamethasone (as valerate)
Dosage Form
Cream
Dosage Strength
10 mg/10 mg/1 mg/500 mcg per g
Manufacturer
Ashford Pharmaceutical Laboratories, Inc.
Trader
Vendiz Pharmaceuticals, Inc.
Issuance Date
27 April 2022
Expiry Date
09 July 2027
Pharmacologic Category
Antifungal-Quinoline Derivative-Anti-infective-Corticosteroid Combination
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8ab75addc733da93
Type
Standard
Back to Philippines FDA Approvals